alexa Interleukin 23 P 19 Expression in Patients with Ulcerat

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Interleukin 23 P 19 Expression in Patients with Ulcerative Colitis and Its Relation to Disease Severity

Hanan El-Bassat1, Lobna Abo Ali1, Sahar El Yamany1, Hanan Al Shenawy1*, Rasha A Al Din2 and Atef Taha3

1Tropical Medicine, Pathology, Tanta University, Egypt

2Microbiology and Immunology and Internal Medicine, Tanta University, Egypt

3Departments, Faculty of Medicine, Tanta University, Egypt

*Corresponding Author:
Hanan Al-Saeid Al-Shenawy
Assistant professor in pathology department
Faculty of Medicine, Tanta University
25 Hamdy Gado street, Tanta, Egypt
Tel: 0020403296201, 00201201892237
E-mail: [email protected]

Received Date: July 18, 2014; Accepted Date: September 24, 2014; Published Date: September 26, 2014

Citation: Bassat HE, Ali LA, Yamany SE, Shenawy HA, Din RAA, et al. (2014) Interleukin 23 P 19 Expression in Patients with Ulcerative Colitis and Its Relation to Disease Severity. J Mol Biomark Diagn 5:191. doi:10.4172/2155-9929.1000191

Copyright: © 2014 Bassat HE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Background and study aims: The purpose of this study is to determine whether mucosal expression of IL 23 p 19 has role in the pathogenesis of ulcerative colitis and its relation to disease severity.

Materials and methods: This study was carried out on 50 patients with ulcerative colitis and 10 normal individuals as control. They were divided into: Group I: 27 patients with mild to moderate disease. Group II: 23 patients with severe disease. Group III: 10 normal individuals. All patients and control were subjected to histopathological study, IL-23p19 immunohistochemical staining, IL-23R expression by flow cytometry and serum IL-23 by ELISA.

Results: There is significant increased in IL-23p19 gene and IL-23R in ulcerative colitis patients compared with control. Significant positive correlation was detected between increased expression of IL-23 p19 gene, IL-23R, high serum IL-23 and severity of the disease.

Conclusions: increased expression of IL-23 p19 is associated with ulcerative colitis and may indicate a role in its pathogenesis and that targeted therapy directed against IL-23 p19 may be effective in the treatment. Also increased expression of IL-23p19 gene and IL-23R with high serum IL-23 correlate positively with disease severity.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version